Companies with a Health score of at least 4, ordered by Health score.
Destiny Pharma plc, a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of medicines for the treatment of infectious diseases in the United Kingdom.
Scancell Holdings plc engages in the discovery and development of novel vaccines for the treatment of various cancers.
Physiomics Plc provides outsourced systems and computational biology services to pharmaceutical companies in the United Kingdom, the European Union, and the United States.
Sareum Holdings plc engages in the discovery and development of therapeutic drugs to treat cancer and autoimmune diseases.
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use within the pharmaceutical and biotechnology industry primarily in the United Kingdom and Malaysia.
Redx Pharma Plc engages in drug discovery, pre-clinical development, and licensing activities in the United Kingdom.
N4 Pharma Plc, a specialist pharmaceutical company, develops and licenses novel therapeutic products pharmaceutical and biotechnology companies in the United Kingdom.
e-Therapeutics plc engages in the discovery of drugs through its proprietary network-driven drug discovery platform in the United Kingdom.
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on develops and commercializes therapies for the treatment of respiratory diseases with unmet medical needs.
C4X Discovery Holdings plc operates as a drug discovery and development company in the United Kingdom.
Evgen Pharma plc, a clinical stage drug development company, engages in developing sulforaphane based medicines for the treatment of multiple diseases.
Bermele plc does not have significant operations.
Avacta Group Plc offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom, North America, Asia, and rest of Europe.
4D pharma plc, together with its subsidiaries, engages in the research, development, and production of live biotherapeutic products.
IXICO plc provides data analytics services to the biopharmaceutical industry in the United States, the United Kingdom, Europe, and internationally.
Silence Therapeutics plc focuses on the discovery, development, and delivery of novel RNA therapeutics in hematology, cardiovascular, and other rare and metabolic indications.